SCHEMBL3847239

SCHEMBL3847239

COc1ccc(N2CCCCC2)c(C(F)(F)F)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.50
HSD17B10 Q99714 2/20 0.50
ALDH1A1 P00352 1/20 0.50
HPGD P15428 1/20 0.50
S1PR1 P21453 3/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
ALOX15 P16050 1/20 0.47
TSHR P16473 1/20 0.47
CYP2C19 P33261 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
NOTUM Q6P988 2/20 0.47
HSD11B1 P28845 1/20 0.45
HTR3E A5X5Y0 1/20 0.44
HTR3B O95264 1/20 0.44
HTR3A P46098 1/20 0.44
HTR3D Q70Z44 1/20 0.44
HTR3C Q8WXA8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14922749 0.86 CCNA2 (0.53) KDM4EALDH1A1HPGDALOX15TSHR
SCHEMBL30345639 0.85 HTR3A (0.64) CYP2C19HTR3EHTR3BHTR3AHTR3D
SCHEMBL14922741 0.85 HTR3A (0.64) CYP2C19HTR3EHTR3BHTR3AHTR3D
SCHEMBL27389206 0.81 NOTUM (0.44) S1PR1NOTUMTAAR1
SCHEMBL8138147 0.79 ALDH1A1 (0.50) KDM4EHSD17B10ALDH1A1HPGDTSHR
SCHEMBL13419179 0.79 NOTUM (0.50) ALDH1A1S1PR1NOTUMHSD11B1
SCHEMBL12017705 0.77 NOTUM (0.51) ALDH1A1S1PR1NOTUMTAAR1
SCHEMBL8129610 0.77 ALDH1A1 (0.51) KDM4EALDH1A1HPGDTSHRHTR3E
SCHEMBL21590281 0.77 HTR3E (0.71) KDM4EHSD17B10ALDH1A1HTR3EHTR3B
SCHEMBL13030868 0.77 ALDH1A1 (0.59) KDM4EHSD17B10ALDH1A1TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7572811-B2 Immunosuppressant compounds and compositions IRM LLC (BM) 2009-08-11 US disclosed
EP-1718307-A4 IMMUNOSUPPRESSANT COMPOUNDS AND COMPOSITIONS IRM LLC (BM) 2009-04-29 EP disclosed
US-20070203100-A1 Immunosuppressant Compounds and Compositions IRM LLC (BM) 2007-08-30 US disclosed
EP-1718307-A2 IMMUNOSUPPRESSANT COMPOUNDS AND COMPOSITIONS IRM, LLC (BM) 2006-11-08 EP disclosed
WO-2005082089-A2 IMMUNOSUPPRESSANT COMPOUNDS AND COMPOSITIONS IRM LLC (BM) 2005-09-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203100-A1 Immunosuppressant Compounds and Compositions ICOS, EDNRA, NFATC1 KDM4E 2364/4885HSD17B10 3581/4885ALDH1A1 3602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.